Literature DB >> 20807250

What is the role of dependence-related behavior in medication-overuse headache?

Françoise Radat1, Michel Lanteri-Minet.   

Abstract

Medication-overuse headache (MOH) can be viewed as an interaction between the worsening of the primary headache course and individual predispositions for dependence. We present here a review of the clinical and biological data raising the role of dependence-related behavior in MOH. Indeed, several clinical studies show that acute headache medications containing psychoactive components (barbiturates, opiates) are associated with an increased risk of MOH. Diagnostic and Statistical Manual of Mental Disorders, 4th edition substance dependence criteria were identified in a sub-group of MOH patients. Comorbidity between MOH and substance-related disorders has also been showed. Recent neuroimaging, biological, and pharmacogenetic studies suggest the existence of an overlap between the pathophysiological mechanisms of MOH and those of substance-related disorders. These data support the proposition of separating 2 sets of MOH patients: the first one in which the illness is mainly due to the worsening of the headache course, and the second one in which behavioral issues are a major determinant of the illness. Detection of a psychological dependence component in a sub-group of MOH patients should have direct relevance to disease management.
© 2010 American Headache Society.

Entities:  

Mesh:

Year:  2010        PMID: 20807250     DOI: 10.1111/j.1526-4610.2010.01755.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  25 in total

Review 1.  Dependent behavior in patients with medication-overuse headache.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients: A Randomized Controlled Clinical Trial.

Authors:  Arão Belitardo Oliveira; Reinaldo Teixeira Ribeiro; Marco Tulio Mello; Sergio Tufik; Mario Fernando Prieto Peres
Journal:  Cannabis Cannabinoid Res       Date:  2019-12-09

3.  Psychopathological profile of medication overuse headache patients, drug assumption and degree of disability.

Authors:  Simone Migliore; Matteo Paolucci; Livia Quintiliani; Claudia Altamura; Giulia D'Aurizio; Giuseppe Curcio; Fabrizio Vernieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 4.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

Review 5.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 6.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

7.  [Preventing and treating medication overuse headache].

Authors:  K B Alstadhaug; H K Ofte; E S Kristoffersen
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

8.  Drug-dependence behaviour and outcome of medication-overuse headache after treatment.

Authors:  Ilenia Corbelli; Stefano Caproni; Paolo Eusebi; Paola Sarchielli
Journal:  J Headache Pain       Date:  2012-10-18       Impact factor: 7.277

9.  Psychiatric screening for migraine patients.

Authors:  O Gambini; B Biagianti; L Grazzi; S Usai; S Scarone; G Bussone
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

10.  Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.

Authors:  Espen Saxhaug Kristoffersen; Jørund Straand; Jūratė Saltytė Benth; Michael Bjørn Russell; Christofer Lundqvist
Journal:  BMC Neurol       Date:  2012-08-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.